Home » Topics » Regulatory

Regulatory
RSS

New expanded indication of Enbrel approved by FDA

June 7, 2000

No Comments

NDA submitted for fast-dissolving Zomig

June 7, 2000

No Comments

Genentech's single-injection clot buster for heart attack approved by FDA

June 7, 2000

No Comments

Schering AG's Yasmin approved in The Netherlands

June 5, 2000

No Comments

3M's QVAR asthma inhaler approved by Health Canada

June 5, 2000

No Comments

BDNF reported to be useful for liver diseases

June 2, 2000

No Comments

Use of pregabalin and related compounds for mania and bipolar disorder

June 2, 2000

No Comments

Olux approved for U.S. marketing

June 2, 2000

No Comments

Anticonvulsants reported useful for alcohol addiction and abuse

June 1, 2000

No Comments

Janssen evaluating combination therapies for Alzheimer's disease and psychosis

June 1, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

New expanded indication of Enbrel approved by FDA

NDA submitted for fast-dissolving Zomig

Genentech's single-injection clot buster for heart attack approved by FDA

Schering AG's Yasmin approved in The Netherlands

3M's QVAR asthma inhaler approved by Health Canada

BDNF reported to be useful for liver diseases

Use of pregabalin and related compounds for mania and bipolar disorder

Olux approved for U.S. marketing

Anticonvulsants reported useful for alcohol addiction and abuse

Janssen evaluating combination therapies for Alzheimer's disease and psychosis

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Regulatory RSS

Regulatory
RSS